List of Tables
Summary Table: Global Market for Life Science Tools and Reagents and COVID-19 Diagnostics, by Type, Through 2029
Table 1: Differences Between Basic and Applied Research
Table 2: Pandemics of the 21st Century
Table 3: Global Market for Life Science Tools and Reagents and COVID-19 Diagnostics, by Type, Through 2029
Table 4: Global Market for COVID-19 Diagnostics Tests, by Type, Through 2029
Table 5: Global Market for COVID-19 Molecular Tests, by Region, Through 2029
Table 6: North American Market for COVID-19 Molecular Tests, by Country, Through 2029
Table 7: European Market for COVID-19 Molecular Tests, by Country, Through 2029
Table 8: Asia-Pacific Market for COVID-19 Molecular Tests, by Country, Through 2029
Table 9: Global Market for COVID-19 Antigen Tests, by Region, Through 2029
Table 10: North American Market for COVID-19 Antigen Tests, by Country, Through 2029
Table 11: European Market for COVID-19 Antigen Tests, by Country, Through 2029
Table 12: Asia-Pacific Market for COVID-19 Antigen Tests, by Country, Through 2029
Table 13: Global Market for COVID-19 Serological Tests, by Region, Through 2029
Table 14: North American Market for COVID-19 Serological Tests, by Country, Through 2029
Table 15: European Market for COVID-19 Serological Tests, by Country, Through 2029
Table 16: Asia-Pacific Market for COVID-19 Serological Tests, by Country, Through 2029
Table 17: Global Market for Life Science Tools and Reagents, by Type, Through 2029
Table 18: Global Market for Life Science Tools and Reagents, by Region, Through 2029
Table 19: North American Market for Life Science Tools and Reagents, by Country, Through 2029
Table 20: European Market for Life Science Tools and Reagents, by Country, Through 2029
Table 21: Asia-Pacific Market for Life Science Tools and Reagents, by Country, Through 2029
Table 22: Global Market for Life Science Instruments, by Region, Through 2029
Table 23: North American Market for Life Science Instruments, by Country, Through 2029
Table 24: European Market for Life Science Instruments, by Country, Through 2029
Table 25: Asia-Pacific Market for Life Science Instruments, by Country, Through 2029
Table 26: Global Market for Life Science Reagents and Kits, by Region, Through 2029
Table 27: North American Market for Life Science Reagents and Kits, by Country, Through 2029
Table 28: European Market for Life Science Reagents and Kits, by Country, Through 2029
Table 29: Asia-Pacific Market for Life Science Reagents and Kits, by Country, Through 2029
Table 30: Global Market for Life Science Tools and Reagents, by Application, Through 2029
Table 31: Global Market for Genomics, by Region, Through 2029
Table 32: North American Market for Genomics, by Country, Through 2029
Table 33: European Market for Genomics, by Country, Through 2029
Table 34: Asia-Pacific Market for Genomics, by Country, Through 2029
Table 35: Global Market for Proteomics, by Region, Through 2029
Table 36: North American Market for Proteomics, by Country, Through 2029
Table 37: European Market for Proteomics, by Country, Through 2029
Table 38: Asia-Pacific Market for Proteomics, by Country, Through 2029
Table 39: Global Market for Cell Biology, Antibodies and Recombinant Proteins, by Region, Through 2029
Table 40: North American Market for Cell Biology, Antibodies and Recombinant Proteins, by Country, Through 2029
Table 41: European Market for Cell Biology, Antibodies and Recombinant Proteins, by Country, Through 2029
Table 42: Asia-Pacific Market for Cell Biology, Antibodies and Recombinant Proteins, by Country, Through 2029
Table 43: Global Market for Stem Cell Research, by Region, Through 2029
Table 44: North American Market for Stem Cell Research, by Country, Through 2029
Table 45: European Market for Stem Cell Research, by Country, Through 2029
Table 46: Asia-Pacific Market for Stem Cell Research, by Country, Through 2029
Table 47: Global Market for Imaging Tools and Techniques, by Region, Through 2029
Table 48: North American Market for Imaging Tools and Techniques, by Country, Through 2029
Table 49: European Market for Imaging Tools and Techniques, by Country, Through 2029
Table 50: Asia-Pacific Market for Imaging Tools and Techniques, by Country, Through 2029
Table 51: Global Market for Animal Models, by Region, Through 2029
Table 52: North American Market for Animal Models, by Country, Through 2029
Table 53: European Market for Animal Models, by Country, Through 2029
Table 54: Asia-Pacific Market for Animal Models, by Country, Through 2029
Table 55: Global Market for Epigenetic Tools and Reagents, by Region, Through 2029
Table 56: North American Market for Epigenetic Tools and Reagents, by Country, Through 2029
Table 57: European Market for Epigenetic Tools and Reagents, by Country, Through 2029
Table 58: Asia-Pacific Market for Epigenetic Tools and Reagents, by Country, Through 2029
Table 59: Global Market for Metabolomics, by Region, Through 2029
Table 60: North American Market for Metabolomics, by Country, Through 2029
Table 61: European Market for Metabolomics, by Country, Through 2029
Table 62: Asia-Pacific Market for Metabolomics, by Country, Through 2029
Table 63: Global Market for Other Applications of Life Science Tools and Reagents, by Region, Through 2029
Table 64: North American Market for Other Applications of Life Science Tools and Reagents, by Country, Through 2029
Table 65: European Market for Other Applications of Life Science Tools and Reagents, by Country, Through 2029
Table 66: Asia-Pacific Market for Other Applications of Life Science Tools and Reagents, by Country, Through 2029
Table 67: Global Market for Life Science Tools and Reagents, by Region, Through 2029
Table 68: North American Market for Life Science Tools and Reagents, by Country, Through 2029
Table 69: North American Market for Life Science Tools and Reagents, by Type, Through 2029
Table 70: North American Market for COVID-19 Diagnostics, by Country, Through 2029
Table 71: European Market for Life Science Tools and Reagents, by Country, Through 2029
Table 72: European Market for Life Science Tools and Reagents, by Type, Through 2029
Table 73: European Market for COVID-19 Diagnostics, by Country, Through 2029
Table 74: Asia-Pacific Market for Life Science Tools and Reagents, by Country, Through 2029
Table 75: Asia-Pacific Market for Life Science Instruments and Reagents, by Type, Through 2029
Table 76: Asia-Pacific Market for COVID-19 Diagnostics, by Country, Through 2029
Table 77: RoW Market for Life Science Instruments and Reagents, by Type, Through 2029
Table 78: Ranking of Life Science Tool and Reagent Companies, by Revenue, 2023
Table 79: Leading Providers of PCR Technologies, by Revenue, 2023
Table 80: Leading Providers of ELISA Instruments/Microplate Readers, by Revenue, 2023
Table 81: Leading Suppliers of Antibodies, by Revenue, 2023
Table 82: Leading Providers of ELISA Tests, by Revenue, 2023
Table 83: Leading Providers of Kits and Assay Tests, by Revenue, 2023
Table 84: Leading Providers of COVID-19 Diagnostics Tools, by Revenue, 2023
Table 85: Recent New Life Science Tools and Reagents, 2022-2024
Table 86: Collaborations in the Life Science Tools and Reagents Market, 2021-2024
Table 87: Recent Acquisitions in the Market for Life Science Tools and Reagents, 2021-2024
Table 88: Other Recent Developments in the Life Science Tools and Reagents Market, 2021-2024
Table 89: ESG Ratings of the Leading Providers of Life Science Tools and Reagents
Table 90: List of Abbreviations Used in the Report
Table 91: Report Sources
Table 92: BD: Company Snapshot
Table 93: BD: Financial Performance, FY 2022 and 2023
Table 94: BD: Product Portfolio
Table 95: BD: News/Key Developments, 2021-2024
Table 96: Bio-Rad Laboratories Inc.: Company Snapshot
Table 97: Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 98: Bio-Rad Laboratories Inc.: Product Portfolio
Table 99: Bio-Rad Laboratories Inc.: News/Key Developments, 2022 and 2023
Table 100: Danaher Corp.: Company Snapshot
Table 101: Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 102: Danaher Corp.: Product Portfolio
Table 103: Danaher Corp.: News/Key Developments, 2021-2023
Table 104: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 105: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 106: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 107: F. Hoffmann-La Roche Ltd.: News/Key Developments, 2021-2023
Table 108: Merck KGaA: Company Snapshot
Table 109: Merck KGaA: Financial Performance, FY 2022 and 2023
Table 110: Merck KGaA: Product Portfolio
Table 111: Merck KGaA: News/Key Developments, 2021 and 2022
Table 112: Promega Corp.: Company Snapshot
Table 113: Promega Corp.: Product Portfolio
Table 114: Promega Corp.: News/Key Developments, 2023 and 2024
Table 115: Qiagen: Company Snapshot
Table 116: Qiagen: Financial Performance, FY 2022 and 2023
Table 117: Qiagen: Product Portfolio
Table 118: Revvity: Company Snapshot
Table 119: Revvity: Financial Performance, FY 2022 and 2023
Table 120: Revvity: Product Portfolio
Table 121: Revvity: News/Key Developments, 2023 and 2024
Table 122: Takara Bio Inc.: Company Snapshot
Table 123: Takara Bio Inc.: Financial Performance, FY 2022 and 2023
Table 124: Taraka Bio Inc.: Product Portfolio
Table 125: Thermo Fisher Scientific Inc.: Company Snapshot
Table 126: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 127: Thermo Fisher Scientific Inc.: Product Portfolio
Table 128: Thermo Fisher Scientific Inc.: News/Key Developments, 2021-2024
List of Figures
Summary Figure: Global Market for Life Science Tools and Reagents and COVID-19 Diagnostics, by Type, 2021-2029
Figure 1: Market Dynamics of Life Sciences Tools and Reagents Market
Figure 2: R&D Spending, by Academic Institutions, 2021-2022
Figure 3: Venture Capital Funding in Life Science, 2021-2022
Figure 4: New Diagnostic Techniques
Figure 5: Percentage of Deaths from Non-Communicable Diseases, by Income Level, 2023
Figure 6: Reasons for Increase in Pandemics
Figure 7: Global Market Shares of COVID-19 Diagnostics, by Type, 2023
Figure 8: Types of ELISA
Figure 9: Global Market for Life Science Tools and Reagents, by Application, 2024 and 2029
Figure 10: Global Market for Life Science Tools and Reagents, by Region, 2021-2029
Figure 11: U.S. Spendings on Life Sciences R&D, 2001 vs. 2019
Figure 12: U.S. Market for Life Science Tools and Diagnostics, 2021-2029
Figure 13: Canadian Market for Life Science Tools and Diagnostics, 2021-2029
Figure 14: Mexican Market for Life Science Tools and Diagnostics, 2021-2029
Figure 15: U.K. Market for Life Science Tools and Diagnostics, 2021-2029
Figure 16: German Market for Life Science Tools and Diagnostics, 2021-2029
Figure 17: French Market for Life Science Tools and Diagnostics, 2021-2029
Figure 18: Rest of the European Market for Life Science Tools and Diagnostics, 2021-2029
Figure 19: Chinese Population Aging Over 60, 2019 and 2040
Figure 20: Chinese Market for Life Science Tools and Diagnostics, 2021-2029
Figure 21: Share of Aging Population in Japan, 2019 and 2040
Figure 22: Japanese Market for Life Science Tools and Diagnostics, 2021-2029
Figure 23: Indian Market for Life Science Tools and Diagnostics, 2021-2029
Figure 24: Rest of Asia-Pacific Market for Life Science Tools and Diagnostics, 2021-2029
Figure 25: Factors Impacting the Environment
Figure 26: BD: Revenue Share, by Business Unit, FY 2023
Figure 27: BD: Revenue Share, by Country/Region, FY 2023
Figure 28: Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 29: Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 30: Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 31: Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 32: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 33: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 34: Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 35: Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 36: Qiagen: Revenue Share, by Business Unit, FY 2023
Figure 37: Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 38: Revvity: Revenue Share, by Business Unit, FY 2023
Figure 39: Revvity: Revenue Share, by Country/Region, FY 2023
Figure 40: Takara Bio Inc.: Revenue Share, by Business Unit, FY 2023
Figure 41: Takara Bio Inc.: Revenue Share, by Country/Region, FY 2023
Figure 42: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 43: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
